Iridex (IRIX) Profit After Tax (QoQ) (2010 - 2026)
Iridex (IRIX) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -184.78% |
| Jan 3, 2026 | 88.30% |
| Sep 27, 2025 | -58.25% |
| Jun 28, 2025 | 41.04% |
| Mar 29, 2025 | -102.16% |
| Dec 28, 2024 | 56.85% |
| Sep 28, 2024 | 27.85% |
| Jun 29, 2024 | 22.66% |
| Mar 30, 2024 | -17.03% |
| Dec 30, 2023 | -68.76% |
| Sep 30, 2023 | 36.59% |
| Jul 1, 2023 | -32.34% |
| Apr 1, 2023 | -82.06% |
| Dec 31, 2022 | 35.03% |
| Oct 1, 2022 | 21.15% |
| Jul 2, 2022 | 6.27% |
| Apr 2, 2022 | -358.49% |
| Jan 1, 2022 | 142.73% |
| Oct 2, 2021 | -255.42% |
| Jul 3, 2021 | 169.30% |